AstraZeneca Crestor Should Be Withdrawn For Safety Risks – Public Citizen
Executive Summary
Public Citizen is citing AstraZeneca's marketing efforts for Crestor as one reason FDA should rapidly withdraw the statin
You may also be interested in...
Crestor European Label Changes Prompt FDA Public Health Advisory
FDA is stressing that physicians should carefully read labeling for AstraZeneca's Crestor after changes to the statin's European label
Crestor European Label Changes Prompt FDA Public Health Advisory
FDA is stressing that physicians should carefully read labeling for AstraZeneca's Crestor after changes to the statin's European label
AstraZeneca Defends Crestor; Public Citizen Renews Call For Withdrawal
The post-marketing safety profile of Crestor is in line with the overall experience of the statin category, AstraZeneca said May 19 in response to a renewed request from Public Citizen for withdrawal of the cholesterol-lowering drug